α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 18 dezembro 2024

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Frontiers Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis

Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases

Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action - ScienceDirect

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Labetalol - an overview

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia - ScienceDirect

Crystal structure of the α1B-adrenergic receptor reveals molecular determinants of selective ligand recognition

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

Recomendado para você